GM2 gangliosidosis insights: Tay-Sachs models via CRISPR-Cas9

被引：0
|
作者：
Suarez, Diego [1 ]
Espejo, Angela J. [1 ]
Almeciga-Diaz, Carlos Javier [1 ]
机构：
[1] Pontificia Univ Javeriana, Inst Errores Innatos Metab, Bogota, Colombia
来源：
MOLECULAR GENETICS AND METABOLISM | 2024年 / 141卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2023.108052
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
313
引用
收藏
页数：2
相关论文
共 50 条
  • [31] QUANTITATION OF HEXA MESSENGER-RNA IN FIBROBLASTS OF TAY-SACHS DISEASES PATIENTS AND IN A LATE-ONSET GM2 GANGLIOSIDOSIS PATIENT WITH A NOVEL MUTATION
    FERNANDES, M
    BOULAY, B
    HECHTMAN, P
    KAPLAN, F
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 1954 - 1954
  • [32] Progranulin associates with hexosaminidase A and ameliorates GM2 ganglioside accumulation and lysosomal storage in Tay-Sachs disease
    Yuehong Chen
    Jinlong Jian
    Aubryanna Hettinghouse
    Xueheng Zhao
    Kenneth D. R. Setchell
    Ying Sun
    Chuan-ju Liu
    Journal of Molecular Medicine, 2018, 96 : 1359 - 1373
  • [33] DETECTION OF GM2-GANGLIOSIDOSIS (TAY-SACHS AND SANDHOFF DISEASE) GENE CARRIERS BY SERUM HEXOSAMINIDASE ASSAY
    MOLZER, B
    BERNHEIMER, H
    CLINICA CHIMICA ACTA, 1976, 73 (01) : 163 - 169
  • [34] Improved Reduction in GM2 Ganglioside Accumulation in Tay-Sachs Mice Using a New Hexosaminidase Variant
    Karumuthil-Melethil, Subha
    Thompson, Patrick
    Walia, Jagdeep S.
    Mark, Brian
    Mahuran, Don
    Gray, Steven J.
    MOLECULAR THERAPY, 2015, 23 : S284 - S284
  • [35] Treatment with recombinant human lysosomal ßhexosaminidase reduces GM2 accumulation in Tay-Sachs disease cells
    Inci, Orhan Kerim
    Leal, Andres F.
    Ates, Nurselin
    Suarez, Diego
    Espejo, Angela J.
    Almeciga-Diaz, Carlos Javier
    Seyrantepe, Volkan
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [36] Crystallographic structure of human β-hexosaminidase A:: Interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis
    Lemieux, M. Joanne
    Mark, Brian L.
    Cherney, Maia M.
    Withers, Stephen G.
    Mahuran, Don J.
    James, Michael N. G.
    JOURNAL OF MOLECULAR BIOLOGY, 2006, 359 (04) : 913 - 929
  • [37] An endogenous detoxification mechanism in Tay-Sachs disease through taurine-conjugation of ganglioside GM2
    Li, Yu-Teh
    Li, Su-Chen
    Crawford, Byron
    Ficarra, Mercedes
    Andersson, Hans
    MOLECULAR GENETICS AND METABOLISM, 2009, 96 (02) : S29 - S29
  • [38] Progranulin associates with hexosaminidase A and ameliorates GM2 ganglioside accumulation and lysosomal storage in Tay-Sachs disease
    Chen, Yuehong
    Jian, Jinlong
    Hettinghouse, Aubryanna
    Zhao, Xueheng
    Setchell, Kenneth D. R.
    Sun, Ying
    Liu, Chuan-ju
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2018, 96 (12): : 1359 - 1373
  • [39] An open-label phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 Gangliosidosis (Tay-Sachs or Sandhoff variants)
    Clarke, Joe
    Mahuran, Don
    Sathe, Swati
    Kolodny, Edwin
    Rigat, Brigitte
    Raiman, Julian
    Tropak, Michael
    MOLECULAR GENETICS AND METABOLISM, 2011, 102 (02) : S12 - S12
  • [40] An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay-Sachs or Sandhoff variants)
    Clarke, Joe T. R.
    Mahuran, Don J.
    Sathe, Swati
    Kolodny, Edwin H.
    Rigat, Brigitte A.
    Raiman, Julian A.
    Tropak, Michael B.
    MOLECULAR GENETICS AND METABOLISM, 2011, 102 (01) : 6 - 12
12345